Repurposing Drugs for Post–COVID-19 Fatigue Syndrome: Methylphenidate, Duloxetine, and Brexpiprazole

No abstract available
Source: American Journal of Therapeutics - Category: Drugs & Pharmacology Tags: Editorial Source Type: research